Predictive Markers for Anti-PD-1/PD-L1 Therapy in NSCLC Predictive Markers for Anti-PD-1/PD-L1 Therapy in NSCLC
What is the current outlook for using predictive markers to guide treatment for patients with NSCLC? What challenges face laboratories implementing these tests?Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Non-Small Cell Lung Cancer